Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001199164 | SCV001370160 | pathogenic | Chondrosarcoma | 2016-01-01 | criteria provided, single submitter | clinical testing | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PP5,PP4,PP3,PM2,PM4,PVS1. |
Labcorp Genetics |
RCV001528142 | SCV005835696 | pathogenic | Multiple congenital exostosis | 2024-05-29 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp517*) in the EXT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EXT1 are known to be pathogenic (PMID: 10679937, 11391482, 19810120). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of hereditary multiple osteochondromatosis (PMID: 19344451, 29126381). ClinVar contains an entry for this variant (Variation ID: 932048). For these reasons, this variant has been classified as Pathogenic. |
Clinical Genetics Laboratory, |
RCV001528142 | SCV001739353 | pathogenic | Multiple congenital exostosis | 2021-05-20 | no assertion criteria provided | clinical testing |